Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing
Support for biologics manufacturability and Industry 4.0 initiatives
Support for biologics manufacturability and Industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines
The partnership will help digitize and automate existing tasks traditionally managed on paper, significantly reducing costs and lead times while increasing compliance
Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
Subscribe To Our Newsletter & Stay Updated